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Looking back can be a sobering exercise for any scien- 
tist. It is true that some important lessons are there to 
be learned, but most of the time breakthroughs and 
new paradigms come from obscure and unpredictable 
beginnings. The Rho GTPase story is no exception to 
this "rule." Rho first surfaced in 1985 when the late 
Pascal Madaule, working as a postdoc with Richard 
Axel, identified a Ras homologous gene in Ap/ysia (Ma- 
daule and Axel, 1985). Was he looking for Ras-related 
proteins? No, he was looking for a snail ortholog of 
human chorionic gonadotropin hormonet The second 
member of the family to be identified, Rac, had no less 
a fortuitous beginning. The protein was purified and 
sequenced in 1989 as a Ras-related C3 transferase sub- 
strate (Didsbury et al., 1989). Only later was it realized 
that the preparation was contaminated with Rho, the 
real C3 substrate. The third member of the family, Cdc42, 
was characterized in John Pringle's lab the following 
year (Johnson and Pringle, 1990). It had a much more 
intellectually satisfying beginning, being the 42 nd cell 
division cycle mutant in Lee Hartwell's yeast screen 
back in the mid-1970s. So how did we get involved in 
this field? Let's start with Alan's story... 
I was recruited as a molecular biologist o my first PI 
position at the Chester Beatty Laboratories in 1981 by 
the newly installed director, Robin Weiss, to work on 
human oncogenes. This was a great opportunity for me, 
but as a naive ex-postdoc who had just been working 
on the expression of recombinant interferon, I was a 
little worried how long the job would last once this cure 
for cancer reached the clinic. As it turned out, of course, 
interferon was not a magic bullet and this was an incredi- 
bly exciting time for a molecular biologist to move into 
cancer research. Numerous viral oncogenes had already 
been characterized, but recently developed assays 
coming out of the Weinberg and Cooper laboratories in 
Boston provided a new technique for isolating real hu- 
man oncogenes. In a wonderful and close partnership 
that lasted 12 years, Chris Marshall and I went on to 
identify and clone a new human oncogene, N-ras (Hall 
et al., 1983). Chris and I spent the rest of the 1980s trying 
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to identify a biochemical function for this regulatory GTP 
binding protein that is mutated in ~30% of human can- 
cers. After some ups (Ras regulates PIP2 hydrolysis) and 
some downs (Ras does not regulate PIP2 hydrolysis), 
my infatuation with Ras began to fade a little. Chris's 
did not and his persistence was rewarded in 1992, when 
he and his PhD student Sally Leevers discovered a major 
function of Ras--to control the activation of the ERK 
MAP kinase pathway (Leevers and Marshall, 1992). 
It was in 1987 that I decided to resurrect hree E. co/i 
strains containing some Ras-like, human cDNAs called 
Rho 6, 9, and 12, which Chris had requested from Pascal 
Madaule a year or so earlier. The plan was to generate 
a constitutively activated version of Rho12 (now called 
RhoA) by site-directed mutagenesis, make recombinant 
protein, and in collaboration with Hugh Paterson, a very 
talented cell biologist in Chris's lab, microinject his into 
fibroblasts to see if it "did anything interesting." The 
following year, and with the help of Connie van Oers (a 
Dutch undergraduate), Annette Self (a Research Assis- 
tant who is still with me today), and Michelle Garrett (a 
PhD student), the first microinjection experiment had 
been done and when I asked Hugh what had happened, 
he said not much--the cells just seemed to make some 
strange shapes. For someone who at that time was 
fixated on cell cycle progression and proliferation, this 
was a rather uninspiring result. 
Concurrent with these goings on, several groups in 
the bacterial toxin field had observed that botulinum 
neurotoxin could ADP-ribosylate a 21 kDa protein and 
there was much excitement that it might be Ras. Work- 
ing with Derek Knight in London, I was able to show 
that it was not, and in 1988 Takai's lab showed that it 
was, in fact, Rho. It soon became clear, however, that 
there was a problem and that the botulinum toxin was 
contaminated with another enzyme called C3 trans- 
ferase. Klaus Aktories (then working in Giessen) and I 
went on to show that C3 transferase could directly ADP- 
ribosylate recombinant Rho protein (Aktories et al., 
1989). During this time, the labs of Michel Popoff, Patrice 
Bouquet, and the late Michael Gill had also been working 
on C3 transferase and had reported that cells treated 
with this enzyme lost most of their actin microfllaments 
(Chardin et al., 1989). They concluded that Rho likely 
controls the actin cytoskeleton. Meanwhile, Hugh and 
I, along with Klaus, who had come (armed with purified 
C3) to do a short sabbatical in London, were in a position 
to publish our first results on the cellular effects of Rho 
in a JCB paper in 1990 (Paterson et al., 1990). Using 
early passage Swiss 3T3 fibroblasts, a wonderfully 
"well-behaved" cell line that we obtained from Enrique 
Rozengurt and which we had used extensively to study 
Ras-induced cell cycle progression, we showed that 
the loss of actin filaments induced by C3 was due to 
inactivation of Rho function. When constitutively acti- 
vated Rho was introduced into subconfluent cells, how- 
ever, it induced unusual morphological changes that 
appeared to be due to cell contraction. Things were 
beginning to look a little more interesting, although we 
still had no real idea what was going on, other than that 
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Rho did something to the actin cytoskeleton. However, 
Hugh's green fingers for cell biology led to a key experi- 
ment, which is shown in the final figure of that paper. 
He noticed that when Swiss 3T3 cells are allowed to 
become confluent and quiescent, much of their actin 
cytoskeleton disappears. When constitutively activated 
Rho is microinjected under these conditions, it induces 
the reappearance of a dense actin filament network. 
Along with Anne's arrival in the lab the same month that 
the JCB paper was published, this result set the scene 
for the work that culminated in the two 1992 Cell papers. 
Moving on to Anne's story... 
I had spent my PhD watching videos of Schwann cells 
responding to Ras (Ridley et al., 1988), and then moved 
to Boston as a postdoc to sequence stretches of the Y 
chromosome. Realizing that I was not destined to be- 
come a genome analyst, I was lured by an advertisement 
in Nature to join Alan's laboratory and return to the 
Ras field. Armed with the latest Boston news from the 
grapevine that the neurofibromatosis gene product NF1 
was a RasGAP, and given that neurofibromatosis is a 
disorder of Schwann cells, my first thoughts were to 
work on this in Alan's laboratory. However, after hearing 
about the effects of Rho on the actin cytoskeleton and 
spending a week reading about stress fibers and mem- 
brane ruffles (frankly, something neither of us knew any- 
thing about), I decided to tackle the Rho project and find 
out if it contributed to growth factor-induced changes to 
the actin cytoskeleton. 
This involved learning to microinject. Fortunately 
Hugh Paterson was a patient teacher, and handled all 
the panic attacks induced by bubbling needles and 
sticky cells without batting an eyelid. He also taught 
me the elusive art of culturing Swiss 3T3 cells without 
allowing them to transform, something that was subse- 
quently a major problem for everyone else who tried to 
follow up our results. Simultaneous to learning micro- 
injection, I grabbed hold of every growth factor and 
stimulant I could find in the laboratory and added them 
to Swiss 3T3 cells to find something that emulated the 
effects of Rho in inducing stress fibers. It did not take 
long to find the best stimulus--fetal calf serum. How- 
ever, it took much longer to isolate the serum component 
responsible. This involved learning the fine art of fast 
performance liquid chromatography (fplc), taught to me 
by Michelle Garrett, who had managed to purify the first 
RhoGAP (Garrett et al., 1991). Little did I know that Chris 
Marshall thought Alan was crazy to even consider purify- 
ing anything from serum, while I spent endless hours in 
the cold room struggling with ailing fraction collectors. 
The fraction that contained the "stress fiber-inducing" 
substance also contained serum albumin, so I plunged 
into the library to unearth obscure papers on what might 
bind to this well-known, sticky protein. This revealed 
that several lipids bound, so to identify the "stress fiber" 
lipid, I used a combination of lipases to knock it out, 
then tested several purified lipids for their effects on 
stress fibers. Amazingly, both routes identified lyso- 
phosphatidic acid (LPA) as the major bioactive compo- 
nent of serum. 
The crucial experiment hat nailed Rho as the mediator 
of stress fiber induction was injecting C3 transferase 
into starved cells and adding back serum or LPA. Pro- 
ducing the photographs to illustrate this was a major 
hurdle. The C3 transferase and LPA had to be titrated 
and lots of time points tested to get the optimal re- 
sponse. After a morning of microinjection I would 
emerge bleary-eyed for a cup of tea, fix and stain the 
samples, and then take reels of photographs. We devel- 
oped all our films and prints by hand in the darkroom-- 
there was no photographic department and no digitized 
images in those days. Each figure represented hours 
in the darkroom playing with developing conditions to 
produce the end product. 
While all this was going on, a new student in the 
laboratory, Dagmar Diekmann, had been set the task of 
cloning the Rac cDNA. Once she had produced constitu- 
tively active Rac in a mammalian expression vector, 
Hugh injected this into Swiss 3T3 cells and when he 
came back the next day, he noticed that it stimulated 
the accumulation of huge cytoplasmic vesicles, which 
turned out to be due to pinocytosis. Meanwhile, I had 
been testing the effects of PDGF and EGF on Swiss 3T3 
cells and found that they induced membrane ruffling. 
(Later, we were politely informed of the difference be- 
tween membrane ruffling and lamellipodia by actin affici- 
onados, but at the time we were content to use the words 
interchangeably.) Ras had previously been reported by 
Jim Feramisco's laboratory to stimulate both membrane 
ruffling and pinocytosis, and so we realized that Rac 
could act similarly. Fortunately, Caroline Johnson had 
just constructed some bacterial GST-Rac vectors for 
her own project, so I purified constitutively active Rac 
protein and found that it stimulated lamellipodium exten- 
sion. Interestingly, it also induced a few stress fibers as 
a later response-the link between Rac and Rho has 
been a source of controversy and discussion ever since. 
Crucial to the completion of the Rac story was the 
construction of a dominant-negative (N17) protein. This 
was a shot in the dark, because at that time only N17Ras 
had been shown to act as a dominant-negative mutant, 
and it was not clear that Rac would behave similarly. 
N17Ras had been shown to have a reduced affinity for 
guanine nucleotides, so we determined the GTP-and 
GDP binding capacities of N17Rac and found that they 
were similar. But the important experiment was micro- 
injecting N17Rac and showing that it inhibited PDGF- 
and EGF-induced membrane ruffling. Again, the experi- 
ment sounds disarmingly simple, but it was difficult to 
purify N17Rac to a high enough concentration to inhibit 
ruffling, and my obsession with time courses and titra- 
tions was essential for finding the optimal conditions 
where inhibition was clear. When all the photographs 
were finally ready and labeled with letraset (who remem- 
bers letraset??), we realized there was way too much 
material for one paper and so divided it into Rho and 
Rac. This made a lot of sense, but was the only thing 
that the two Cell reviewers were really concerned about. 
Amazingly, the only extra experiment hey asked for was 
to inject N17Ras protein and test whether it inhibited 
PDGF-induced membrane ruffling (to our surprise it did 
not). Fortunately, we convinced the editor that it was 
impossible to merge the papers--there were just too 
many figures and they were all essential. We also had 
the advantage that in those "pre-electronic" days, they 
could not be consigned to "supplementary material." 
Despite the struggles with cold rooms, dark rooms, 
microinjection needles, and misbehaving Swiss 3T3 
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cells, these two years were enormously exciting and 
rewarding, The enthusiastic reception of the poster on 
our work at the Cold Spring Harbor Symposium in 1992 
made all the effort worthwhile. It is true that we all had to 
spend a lot of time catching up on the actin cytoskeleton 
literature, but fortunately it was worth it and its relevance 
to so much of eukaryotic cell biology is now taken for 
granted. 
During the same period, Rac was hitting the headlines 
for other reasons. Alan's laboratory discovered that Bcr 
was a GAP for Rac (Diekmann et al., 1991) and with 
Tony Segal, Arie Abo, and Edgar Pick showed that Rac 
activates the NADPH oxidase enzyme complex (Abo et 
al., 1991). The link between Rac and the NADPH oxidase 
persisted as an oddity for another 3 or 4 years, before 
we realized that it was the tip of an iceberg of additional, 
nonactin functions controlled by these GTPases. A flurry 
of papers in 1995, showing that Rho, Rac, and Cdc42 
regulated gene transcription (Coso et al., 1995; Hill et 
al., 1995; Minden et al., 1995), started the ball rolling, 
while work initiated in yeast revealed the special and 
intimate relationship between Cdc42 and the establish- 
ment of cell polarity (reviewed in Pruyne and Bretscher, 
2000). One of the more interesting recent developments 
has been the emergence of Rho, Rac, and Cdc42 as key 
regulators of the microtubule cytoskeleton (reviewed in 
Wittmann and Waterman-Storer, 2001). We had looked 
for a possible link using Swiss 3T3 cells back in 1990, but 
the microtubule cytoskeleton does not simply disappear 
upon serum starvation and so we missed the more sub- 
tle, but no less important, effects of Rho and Rac on 
microtubule dynamics. 
In conclusion, it has been a real privilege to have 
identified the two signal transduction pathways linking 
Rho and Rac to the actin cytoskeleton and to be part 
of the subsequent explosion of activity surrounding Rho 
GTPases. We could never have anticipated the response 
generated by our research and the huge impact that 
Rho GTPases would have on so many areas of biology. 
We were fortunate that circumstances, largely out of 
our control, converged at the right place and the right 
time, and we have snails, Swiss 3T3, and serum to thank 
for making such a wonderful Rac 'n' Rho story. 
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Summary 
Actin stress fibers are one of the major cytoskeletal 
structures in fibroblasts and are linked to the plasma 
membrane at focal adhesions, rho, a ras-related GTP- 
binding protein, rapidly stimulated stress fiber and fo- 
cal adhesion formation when microinjected into serum- 
starved Swiss 3T3 cells. Readdition of serum produced 
a similar response, detectable within 2 min. This activity 
was due to a lysophospholipid, most likely lysophos- 
phatidic acid, bound to serum albumin. Other growth 
factors including PDGF induced actin reorganization 
initially to form membrane ruffles, and later, after 5 to 
t0 min, stress fibers. For all growth factors tested the 
stimulation of focal adhesion and stress fiber assem- 
bly was inhibited when endogenous rho function was 
blocked, whereas membrane ruffling was unaffected. 
These data imply that rho is essential specifically for 
the coordinated assembly of focal adhesions and 
stress fibers induced by growth factors. 
Introduction 
The discovery that many human cancers contain onco- 
genic mutations in ras genes has stimulated much inter- 
est in the biological roles of ras and ms-related GTP-binding 
proteins (Bos, 1988; Downward, 1990; Hall, 1990). Over 
40 low molecular weight GTPases related to ras have now 
been identified, and they regulate a diverse range of cellu- 
lar processes. Based on sequence homology, this super- 
family can be divided into four subfamilies, ms, rho, rab, 
and arf, a grouping that also reflects similarities in function. 
There is now considerable vidence that the ras proteins 
themselves are essential components of receptor-medi- 
ated signal transduction pathways timulating prolifera- 
tion and differentiation (Hall, 1990; Downward, 1990). In 
contrast, members of the rab and arf subfamilies are 
thought o regulate the transport of vesicles between intra- 
cellular compartments (Balch, 1990; Serafini et al., 1991; 
Kahn et al., 1991). 
The mammalian rho subfamily comprises the three 
highly related proteins rhoA, rhoB, and rhoC, two rac pro- 
teins, TC10, and two CDC42Hs proteins (also known as 
G25K) (Hall, 1990; Shinjo et al., 1990). In addition, three 
related genes, CDC42Sc, RH01, and RH02, have been 
cloned from Saccharomyces cerevisiae (Johnson and 
Pringle, 1990). Characterization of the mammalian rho 
proteins has shown that they bind and hydrolyze GTP and 
that their intrinsic GTPase activity is stimulated by a 
GTPase-activating protein, rhoGAP, found in many cell 
types (Garrett et al., 1989, 1991). Mutation of amino acid 
14 from Gly to Val, equivalent o the Val-12 oncogenic 
mutation in ras, decreases the intrinsic GTPase activity of 
rho proteins and makes them unresponsive to rhoGAP 
(Garrett et al., 1989). rhoGAP is also active on rac, 
whereas two proteins with sequence homology to rhoGAP, 
Bcr (the breakpoint cluster egion gene product) and n-chi- 
merin, act as GAPs for rac but not rho (Diekmann et al., 
1991). Three other proteins have been described that can 
interact with rho and rac in vitro, rhoGDI inhibits dissocia- 
tion of GDP but not GTP from rho and rac, while smgGDS 
stimulates exchange of GDP for GTP on rho, rac, Ki-ras, 
and rap1 proteins (Fukumoto et al., 1990; Mizuno et al., 
1991; Hiraoka et al., 1992). Another activity named 
rhoGDS has been partially purified and stimulates nucleo- 
tide exchange on rho but not rap, and it is therefore proba- 
bly distinct from smgGDS (Isomura et al., 1990). 
The first clues to a biological function for rho proteins 
came through the use of an exoenzyme produced by Clos- 
tridium botulinum, the C3 transferase, which ADP-ribo- 
sylates rho proteins on amino acid Asn-41 (Aktories et 
al., 1989; Sekine et al., 1989). When C3 transferase is 
introduced into a vadety of cell types, they lose their actin 
stress fibers and round up (Rubin et al., 1988; Chardin et 
al., 1989; Paterson et al., 1990). More direct evidence that 
rho acts on the actin cytoskeleton came from microinject- 
ing cells with recombinant rho proteins or plasmids ex- 
pressing rho cDNAs, rho was found to induce a rapid reor- 
ganization of actin into stress fibers in a variety of cell lines 
(Paterson et al., 1990). These results suggest that rho 
proteins are involved in regulating the organization of poly- 
merized actin. 
A role for the actin cytoskeleton has been implicated 
in many cellular functions, including motility, chemotaxis, 
cell division, endocytosis, and secretion (Devreotes and 
Zigmond, 1988; Salmon, 1989; Bretscher, 1991). Precise 
temporal and spatial control of actin filament organization 
is essential for these activities, but how this is achieved is 
not known. In fibroblasts, actin filaments exist principally 
in three types of structure, the cortical actin network, actin 
stress fibers, and cell surface protrusions including mem- 
brane ruffles and microspikes (Small, 1988). Stress fibers 
emanate from distinct areas of the plasma membrane 
known as focal adhesions, where clusters of integrin re- 
ceptors bind to extracellular matrix proteins such as flbro- 
nectin and collagen. A number of proteins are found 
associated with focal adhesions at the intracellular face of 
the plasma membrane, including vinculin, talin, tensin, and 
c~-actinin (Burridge et al., 1988). Some of the interactions 
between these proteins, actin, and integrin receptors have 
been characterized, but little is known of the molecular 
mechanisms controlling focal adhesion and stress fiber 
formation (Burridge et al., 1988; Turner and Burridge, 
1991). 
We have analyzed early changes in actin organization 
following the stimulation of quiescent serum-starved 
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Summary 
The function of rac, a ras-related GTP-binding protein, 
was investigated in fibroblasts by microinjection. In 
confluent serum-starved Swiss 31"3 cells, racl rapidly 
stimulated actin filament accumulation at the plasma 
membrane, forming membrane ruffles. Several growth 
factors and activated H-ras also induced membrane 
ruffling, and this response was prevented by a domi- 
nant inhibitory mutant rac protein, N17rac1. This sug- 
gests that endogenous rac proteins are required for 
growth factor-induced membrane ruffling. In addition 
to membrane ruffling, a later response to both racl 
microinjection and some growth factors was the for- 
mation of actin stress fibers, a process requiring en- 
dogenous rho proteins. Using N17rac1 we have shown 
that these growth factors act through rac to stimulate 
this rho-dependent response. We propose that rac and 
rho are essential components of signal transduction 
pathways linking growth factors to the organization of 
polymerized actin. 
Introduction 
The small GTP-binding proteins racl and rac2 are 92% 
homologous to each other and belong to the rho subfamily 
of ras-related proteins (Didsbury et al., 1989; Hall, 1990). 
Like all other members of the ras superfamily, they bind 
and hydrolyze GTP, and several proteins have been identi- 
fied that can regulate nucleotide exchange or stimulate 
their intrinsic GTPase activity in vitro (Diekmann et al., 
1991; Hiraoka et al., 1992). The racl gene is expressed in 
a variety of tissues and cell lines, whereas rac2 expression 
appears to be restricted to cells of hemopeietic lineages 
(Didabury et al., 1989; Shirsat et al., 1990; Moll et al., 1991) 
and is increased severalfold when the myeloid precursor 
cell line HL60 is induced to differentiate to a neutrophil-like 
morphology (Didsbury et al., 1989). 
Recently a specialized role for rac has been identified 
in phagocytic cells--activation of an NADPH oxidase to 
generate superoxide. This is part of a coordinated antibac- 
terial defense mechanism, in which bacteria are phagocy- 
tosed and toxic superoxide is released into phagosomes 
(Morel et al., 1991). Both racl and rac2 have been inde- 
pendently purified from phagocytes as activators of super- 
oxide production in a reconstituted in vitro assay (Abo et 
al., 1991; Knaus et al., 1991). Addition of purified recombi- 
nant racl bound to the nonhydrolyzable GTP analog GTP- 
~S, but not to GDP, stimulates the production of superox- 
ide in this assay (Abe et al., 1991). Two cytoplasmic 
proteins, p47 and p67, are also required to activate the 
membrane-bound NADPH oxidase, and their expression 
is restricted to myeloid cells (Morel et al., 1991). racl, 
however, is expressed in other cell types and is therefore 
likely to have another function distinct from its role in 
phagocyte-specific superoxide generation. Other mem- 
bers of the rho subfamily appear to be involved in regulat- 
ing actin organization. For example, the mammalian rho 
proteins have been shown to regulate the formation of 
actin stress fibers in fibroblasts (Paterson et aL, 1990; 
Ridley and Hall, 1992, see accompanying paper in this 
issue of Cell). In addition, CDC42Sc, the Saccharomyces 
cerevisiae homolog of CDC42Hs, is involved in controlling 
cell polarity, which is linked to the spatial organization 
of polymedzed actin (Adams et al., 1990; Johnson and 
Pringle, 1990). We have therefore studied the effects of 
racl on the actin cytoskeleton of fibroblasts. 
Results 
racl Stimulates Pinocytosis 
and Membrane Ruffling 
To gain insight into the function of rac, we microinjected 
a euka~otic expression vector encoding activated racl 
with a mutation of amino acid 12 from Gly ((3) to Val (V) 
(pEXV-V12rac1, equivalent o the V12 oncogenic mutation 
in ras) into the nuclei of subconfluent Rat2 fibroblasts. 
As with ras, this mutation decreases the intrinsic GTPase 
activity of racl and makes it unresponsive to GTPase- 
activating proteins (GAPs) (Diekmann et al., 1991). To 
identify which cells were expressing the construct, the pro- 
tein was tagged with a myc epitope recognized by the 
monoclonal antibody 9E10 at its N-terminus (Evan et al., 
1985). The cells were observed by cinemicroscopy to de- 
termine whether racl expression led to a distinct pheno- 
type. Six hours following injection vesicles began to ap- 
pear, increasing in number and size until they filled the 
whole cytoplasm (Figure 1 b). V12rac1 was found by immu- 
nofluorescence to be localized to the surface of the vesi- 
cles and also to the plasma membrane (Figure la). Most 
microinjected cells eventually rounded up and detached 
from the substratum. As a control, cells were injected with 
a vector encoding a mutant racl protein with amino acid 
35 changed from Thr (T) to Ala (A) (pEXV-V12A35rac1). 
This amino acid is conserved in all members of the ras 
superfamily, and has been shown to be essential for ms 
function (Bourne et al., 1991). No vesicle formation was 
observed in cells injected with pEXV-V12A35rac1. 
The appearance of large vesicles in fibroblasts is most 
likely due either to an increase in uptake of plasma mem- 
brane vesicles by a pinocytotic mechanism or to the abnor- 
mal accumulation of an intracellular trafficking compart- 
ment. To distinguish between these two possibilities, 
uptake of culture medium containing the fluorescent dye 
